Financial insights of BBIO

MyFinsight

For the year ending 2025-12-31, BBIO made $502,076K in revenue. -$724,931K in net income. Net profit margin of -144.39%.

Income Statement	2025-12-31	2024-12-31
Total revenues, net	502,076	221,902
Product	15,687	-
License Services And Royalty	5,275	-
Total cost of revenues	20,962	3,878
Research and development	451,953	506,461
Restructuring, impairment and related charges	-	15,605
Selling, general and administrative	531,225	288,931
Restructuring, impairment, and related charges	21,347	-
Total operating costs and expenses	1,025,487	814,875
Loss from operations	-523,411	-592,973
Interest income	19,854	17,249
Interest expense	53,103	99,290
Noncash interest expense on deferred royalty obligations	125,138	-
Gain on deconsolidation of subsidiaries	0	178,321
Loss on extinguishments of debt	-21,155	-26,590
Net loss from equity method investments	-72,608	-31,183
Other income, net	43,058	12,272
Total other income (expense), net	-209,092	50,779
Loss before income taxes	-732,503	-542,194
Provision for income taxes	435	1,153
Net loss	-732,938	-543,347
Net loss attributable to redeemable convertible noncontrolling interests and noncontrolling interests	-8,007	-7,585
Net loss attributable to common stockholders of bridgebio	-724,931	-535,762

Basic EPS	-3.78	-2.88
Diluted EPS	-3.78	-2.88
Basic Average Shares	191,527,482	186,075,873
Diluted Average Shares	191,527,482	186,075,873